Login to Your Account



Resolve Partners Preclinical Lupus Therapy in Takeda Deal

By Catherine Shaffer
Staff Writer

Friday, March 1, 2013
A new deal with Takeda Pharmaceutical Co. Ltd. will help Resolve Therapeutics LLC, of Seattle, forge ahead through clinical proof of concept with its investigational systemic lupus erythematosus therapy, RSLV-132.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription